23
Apr
2010
HemaQuest Pharmaceuticals, Inc. Series B $12M
Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Antiviral, X - EBV, X - HIV, X - HPV, X - Hemoglobin, X - Sickle Cell, XX - MA
HemaQuest Pharmaceuticals (Newton, MA) a clinical-stage small molecule company focused on hemoglobin disorders such as sickle cell disease, beta thalassemia, and viral-associated disease such as HPV, EBV and HIV, closed a $12M Series B financing. Participants include Aberdare Ventures, De Novo Ventures, Forward Ventures and Lilly Ventures.
OnBioVC PARTNERS
-
